[go: up one dir, main page]

WO2007026038A3 - Use of a mycosporin-type amino acid (shinorine) as an antioxidant - Google Patents

Use of a mycosporin-type amino acid (shinorine) as an antioxidant Download PDF

Info

Publication number
WO2007026038A3
WO2007026038A3 PCT/ES2006/000492 ES2006000492W WO2007026038A3 WO 2007026038 A3 WO2007026038 A3 WO 2007026038A3 ES 2006000492 W ES2006000492 W ES 2006000492W WO 2007026038 A3 WO2007026038 A3 WO 2007026038A3
Authority
WO
WIPO (PCT)
Prior art keywords
shinorine
mycosporin
amino acid
antioxidant
type amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/ES2006/000492
Other languages
Spanish (es)
French (fr)
Other versions
WO2007026038A2 (en
Inventor
La Coba Luque Francisca De
Arjona Jose Aguilera
Figueroa Felix Lopez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad de Malaga
Original Assignee
Universidad de Malaga
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad de Malaga filed Critical Universidad de Malaga
Publication of WO2007026038A2 publication Critical patent/WO2007026038A2/en
Publication of WO2007026038A3 publication Critical patent/WO2007026038A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/04—Rhodophycota or rhodophyta (red algae), e.g. Porphyra
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A61K8/9717—Rhodophycota or Rhodophyta [red algae], e.g. Porphyra
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9733—Lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychology (AREA)
  • Toxicology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a mycosporin-type amino acid (shinorine) which can be used as an antioxidant and which is suitable for use in the biotechnological industry. The invention outlines the potential use of a mycosporin-type amino acid (MAA) as an antioxidant substance, specifically shinorine isolated from red alga Gymnogongrus devoniensis, and to the possible use thereof in pharmaceutical, nutraceutical or functional food preparations, among others, for the prevention of oxidative stress.
PCT/ES2006/000492 2005-08-31 2006-08-28 Use of a mycosporin-type amino acid (shinorine) as an antioxidant Ceased WO2007026038A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ESP200502157 2005-08-31
ES200502157A ES2284344B1 (en) 2005-08-31 2005-08-31 USE OF AMINO ACID TYPE MICOSPORINE (SHIMORINE) IN PRODUCTS FOR PREVENTION AND TREATMENT OF PARKINSON AND ALZHEIMER.

Publications (2)

Publication Number Publication Date
WO2007026038A2 WO2007026038A2 (en) 2007-03-08
WO2007026038A3 true WO2007026038A3 (en) 2007-05-24

Family

ID=37809233

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2006/000492 Ceased WO2007026038A2 (en) 2005-08-31 2006-08-28 Use of a mycosporin-type amino acid (shinorine) as an antioxidant

Country Status (2)

Country Link
ES (5) ES2284344B1 (en)
WO (1) WO2007026038A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2032122T1 (en) * 2006-06-27 2016-10-28 Nutratec S.R.L. Extracts of aphanizomenon flos aquae (afa klamath), active compounds, and their uses

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2803201A1 (en) * 1999-12-30 2001-07-06 Gelyma Algal extracts containing amino acid analogs of mycosporin are useful as dermatological protecting agents against ultraviolet radiation
WO2002039974A1 (en) * 2000-11-17 2002-05-23 Natural Environment Research Council Personal care compositions
EP1473028A1 (en) * 2003-04-30 2004-11-03 Mibelle AG Cosmetic skin care products and cosmetic agents for protecting skin against premature aging

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5849346A (en) * 1981-09-18 1983-03-23 Mitsubishi Chem Ind Ltd Mycosporine amino acids and their derivatives
FR2655268B1 (en) * 1989-12-06 1994-10-14 Secma USE OF ALGAE EXTRACTS FOR THE PREPARATION OF PHARMACEUTICAL, COSMETIC, FOOD OR AGRICULTURAL COMPOSITIONS.
CA2251457A1 (en) * 1998-10-23 2000-04-23 Norman Huner Compositions including naturally occurring compounds from plants, algae and cyanobacteria for protection against solar radiation
ATE420623T1 (en) * 2001-11-14 2009-01-15 Larena MEDIUM CONTAINING A RED ALGAE EXTRACT OF THE GENUS PORPHYRA AND ITS USE TO PROTECT CELLS
FR2876004B1 (en) * 2004-10-01 2007-04-06 Exsymol Sa Monegasque USE OF RED ALGAE SUBJECTED TO EXTREME CONDITIONS OF TEMPERATURE AND BRIGHTNESS
FR2882894B1 (en) * 2005-03-11 2009-04-03 Larena Sa SUPPLETIVE FOOD COMPOSITION

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2803201A1 (en) * 1999-12-30 2001-07-06 Gelyma Algal extracts containing amino acid analogs of mycosporin are useful as dermatological protecting agents against ultraviolet radiation
WO2002039974A1 (en) * 2000-11-17 2002-05-23 Natural Environment Research Council Personal care compositions
EP1473028A1 (en) * 2003-04-30 2004-11-03 Mibelle AG Cosmetic skin care products and cosmetic agents for protecting skin against premature aging

Also Published As

Publication number Publication date
ES2284344A1 (en) 2007-11-01
ES2301428A1 (en) 2008-06-16
ES2301428B1 (en) 2009-05-01
ES2284344B1 (en) 2008-11-01
ES2301426B1 (en) 2009-05-01
WO2007026038A2 (en) 2007-03-08
ES2301426A1 (en) 2008-06-16
ES2301427B1 (en) 2009-05-01
ES2301425B1 (en) 2009-05-01
ES2301427A1 (en) 2008-06-16
ES2301425A1 (en) 2008-06-16

Similar Documents

Publication Publication Date Title
Hayes et al. Boarfish protein recovery using the pH-shift process and generation of protein hydrolysates with ACE-I and antihypertensive bioactivities in spontaneously hypertensive rats
Tantoush et al. Green tea catechins of food supplements facilitate pepsin digestion of major food allergens, but hampers their digestion if oxidized by phenol oxidase
WO2011100763A3 (en) Ruminant dietary supplement compositions and methods of manufacturing and using the same
MX2021014701A (en) Eutectic extraction of solids.
Nwachukwu et al. Antioxidant properties of flaxseed protein hydrolysates: influence of hydrolytic enzyme concentration and peptide size
WO2003041679A3 (en) Product containing a red alga extract of the genus porphyra and uses thereof for protecting cells
WO2008036932A3 (en) Compositions and methods comprising boswellia species
WO2007059715A8 (en) Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses
WO2007079139A3 (en) Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
WO2010130832A3 (en) Amino acid sequences directed against dickkopf-1 and polypeptides comprising the same for the treatment of diseases and disorders associated with bone loss and/or osteolytic lesions
ZA200810840B (en) Extracts of aphanizomenon flos aquae and nutritional, cosmetic and pharmaceutical compositions containing the same
WO2008087367A3 (en) Substituted (phenylthiazolyl)-phenyl-propan-1-one and (phenyloxazodyl)-phenyl-propan-1-one derivatives, preparations and uses of same
Kannan et al. Colon and breast anti-cancer effects of peptide hydrolysates derived from rice bran
WO2005082927A3 (en) Antihypertensive peptides
IL186050A0 (en) Novel isoindole derivatives, compositions containing same, preparation thereof and pharmaceutical uses thereof in particular as inhibitors of chaperone protein hsp90 activities
WO2007016591A3 (en) Compositions and methods for monitoring and altering protein folding and solubility
WO2011152330A1 (en) Soybean protein hydrolysate-containing antioxidant and use thereof
WO2009125409A3 (en) Fatty acid amides and uses thereof
WO2007053390A3 (en) Methods for the use of branched chain amino acids
WO2006042661A3 (en) Oligopeptides and their use in cosmetics
NZ585092A (en) Food material for inhibiting osteoclastogenesis
WO2005074989A3 (en) Combination of a dna topoisomerase inhibitor and an iap inhibitor
WO2008051448A3 (en) Methods and compositions for efficient removal of protein a from binding molecule preparations
WO2007026038A3 (en) Use of a mycosporin-type amino acid (shinorine) as an antioxidant
WO2007026035A3 (en) Use of a mycosporin-type amino acid (porphyra 334) as an antioxidant

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06807937

Country of ref document: EP

Kind code of ref document: A2